Identifying Potential Off-Target Protein Binders of Glutamate-Ureido-Lysine, a Prostate Cancer Specific Imaging Agent

08 October 2020, Version 3

Abstract

Prostate-specific membrane antigen (PSMA) is highly overexpressed in most prostate cancers and is clinically visualized using PSMA-specific probes incorporating Glutamate-Ureido-Lysine (GUL). PSMA is effectively absent from certain high-mortality, treatment-resistant subsets of prostate cancers, such as neuroendocrine prostate cancer (NEPC); however, GUL-based probes still sometimes identify NEPC metastatic tumours. These probes may bind unknown proteins associated with PSMA-suppressed cancers. We identified the upregulation of PSMA-like aminopeptidase NAALADaseL and the metabotropic glutamate receptors (mGluRs) in NEPC; we found that the expression levels inversely correlate with PSMA expression and are associated with poor clinical prognosis indicating they may participate in NEPC disease progression. Computationally predicting that GUL-based probes bind well to these targets, we designed and synthesized a new fluorescent probe to investigate these proteins in vitro, where it shows excellent affinity for PSMA, NAALADaseL and specific mGluRs associated with poor prognosis.

Keywords

prostate cancer
PSMA
Glutmaate-Ureido-Lysine
molecular imaging
PET
glutamate receptors
neuroendocrine

Supplementary materials

Title
Description
Actions
Title
2020-10-07-Supporting Information V12
Description
Actions
Title
Video S1 PSMA Cy3-GUL new
Description
Actions
Title
Video S2 NAALAD1 Cy3-GUL
Description
Actions
Title
Video S3 mglur8 Cy3-GUL
Description
Actions
Title
Video S4
Description
Actions
Title
Video S5 NAALAD1 F-GUL
Description
Actions
Title
Video S6 mglur8 F-GUL
Description
Actions
Title
Video S7 PSMA Ga-GUL
Description
Actions
Title
Video S8 NAALAD1 Ga-GUL
Description
Actions
Title
Video S9 mglur8 Ga-GUL
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.